(Q28212641)

https://api.crossref.org/works/10.1074%2FJBC.M101707200

Acetylation: a regulatory modification to rival phosphorylation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M101707200

Histone acetylation in chromatin and chromosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M101707200

Histone acetylation in chromatin structure and transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M101707200

Histone acetylation and transcriptional regulatory mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M101707200

Acetylation of histones and transcription-related factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M101707200

Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M101707200

DNA damage activates p53 through a phosphorylation-acetylation cascade

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M101707200

p53 sites acetylated in vitro by PCAF and p300 are acetylated in vivo in response to DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M101707200

Regulation of E2F1 activity by acetylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M101707200

Regulation of activity of the transcription factor GATA-1 by acetylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M101707200

Acetylation of HMG I(Y) by CBP turns off IFN beta expression by disrupting the enhanceosome

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M101707200

Histone deacetylase inhibitors: inducers of differentiation or apoptosis of transformed cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M101707200

Rapid induction of histone hyperacetylation and cellular differentiation in human breast tumor cell lines following degradation of histone deacetylase-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M101707200

Synergistic coupling of histone H3 phosphorylation and acetylation in response to epidermal growth factor stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M101707200

Histone acetylation in signal transduction by growth regulatory signals

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M101707200

Histone acetyltransferase activity of CBP is controlled by cycle-dependent kinases and oncoprotein E1A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M101707200

The growing family of interferon regulatory factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M101707200

Cell cycle regulation of histone H4 gene transcription requires the oncogenic factor IRF-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M101707200

Co-occupancy of the interferon regulatory element of the class II transactivator (CIITA) type IV promoter by interferon regulatory factors 1 and 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M101707200

Interferon regulatory factor 3 and CREB-binding protein/p300 are subunits of double-stranded RNA-activated transcription factor DRAF1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M101707200

Direct triggering of the type I interferon system by virus infection: activation of a transcription factor complex containing IRF-3 and CBP/p300.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M101707200

Selective DNA binding and association with the CREB binding protein coactivator contribute to differential activation of alpha/beta interferon genes by interferon regulatory factors 3 and 7.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M101707200

Recruitment of CBP/p300 by the IFN beta enhanceosome is required for synergistic activation of transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M101707200

Retracted: Three unrelated viral transforming proteins (vIRF, EBNA2, and E1A) induce the MYC oncogene through the interferon-responsive PRF element by using different transcription coadaptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M101707200

Inhibition of p300 histone acetyltransferase by viral interferon regulatory factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M101707200

The histone acetylase PCAF is a phorbol-ester-inducible coactivator of the IRF family that confers enhanced interferon responsiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M101707200

The transcriptional coactivators p300 and CBP are histone acetyltransferases

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M101707200

Enhanced phosphorylation of nuclear 21-kDa and 34-kDa proteins in hepatoma cell death induced by tumor-necrosis factor-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M101707200

Inducible processing of interferon regulatory factor-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M101707200

p300 is required for MyoD-dependent cell cycle arrest and muscle-specific gene transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M101707200

Increased affinity of c-Myb for CREB-binding protein (CBP) after CBP-induced acetylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M101707200

p300 requires its histone acetyltransferase activity and SRC-1 interaction domain to facilitate thyroid hormone receptor activation in chromatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M101707200

A p300/CBP-associated factor that competes with the adenoviral oncoprotein E1A

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M101707200

Histone-like TAFs within the PCAF histone acetylase complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M101707200

The 400 kDa subunit of the PCAF histone acetylase complex belongs to the ATM superfamily

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M101707200

c-Myb acetylation at the carboxyl-terminal conserved domain by transcriptional co-activator p300.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M101707200

Regulation of interaction of the acetyltransferase region of p300 and the DNA-binding domain of Sp1 on and through DNA binding.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M101707200

Acetylation of MyoD directed by PCAF is necessary for the execution of the muscle program

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M101707200

Overlapping but distinct patterns of histone acetylation by the human coactivators p300 and PCAF within nucleosomal substrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M101707200

Anti-oncogenic and oncogenic potentials of interferon regulatory factors-1 and -2

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M101707200

Transcription factors IRF-1 and IRF-2: linking the immune responses and tumor suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M101707200

Drosophila CBP represses the transcription factor TCF to antagonize Wingless signalling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M101707200

PU.1, interferon regulatory factor 1, and interferon consensus sequence-binding protein cooperate to increase gp91(phox) expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M101707200